Should I Buy TACT? TACT 2026 Analysis

Should You Buy TransAct Technologies Inc (TACT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

3.570

1 Day change

-1.65%

52 Week Range

5.700

Analysis Updated At

2026/01/26

TransAct Technologies Inc (TACT) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, options data shows limited trading activity, and financial performance is mixed with declining net income and EPS despite revenue growth. There are no positive news catalysts or significant trading signals to support immediate investment.

Technical Analysis

The stock is currently in a bearish trend with MACD below zero and negatively expanding, RSI at 27.531 (neutral), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support and resistance levels indicate the stock is trading near its support zone (S1: 3.62, S2: 3.433).

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

Revenue increased by 21.25% YoY in Q3 2025, and gross margin improved by 3.45% YoY.

Neutral/Negative Catalysts

Net income dropped by -102.72% YoY, EPS fell to 0 (-100% YoY), no recent news or significant insider/hedge fund activity, and no recent congress trading data. Technical indicators are bearish, and the stock has a 60% chance of declining 2.68% in the next week.

Financial Performance

In Q3 2025, revenue grew to $13.176M (up 21.25% YoY), but net income fell to $15K (-102.72% YoY), and EPS dropped to 0 (-100% YoY). Gross margin improved to 49.76% (up 3.45% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available.

1 Analyst Rating

Wall Street analysts forecast TACT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TACT is 5 USD with a low forecast of 5 USD and a high forecast of 5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 3.630

Low

Averages

High

Current: 3.630

Low

Averages

High

Roth Capital

Jeff Martin

Buy

downgrade

$6 -> $5

AI Analysis

2025-05-14

Reason

Roth Capital

Jeff Martin

Price Target

$6 -> $5

AI Analysis

2025-05-14

downgrade

Buy

Reason

Roth Capital analyst Jeff Martin lowered the firm's price target on TransAct Technologies to $5 from $6 and keeps a Buy rating on the shares. The firm notes that its prior thesis was based, in part, on a positive outcome from the strategic business review, which has now been suspended. FST and Casino & Gaming segments are performing well while the outlook for TransAct in 2025 remains breakeven to modestly negative on an adjusted EBITDA basis, the analyst tells investors in a research note.

TACT Should I Buy

TACT Should I Buy

Should You Buy TransAct Technologies Inc (TACT) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch